BENUSSI, Alberto
 Distribuzione geografica
Continente #
NA - Nord America 7.650
AS - Asia 4.751
EU - Europa 3.301
SA - Sud America 917
AF - Africa 123
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 7
Totale 16.765
Nazione #
US - Stati Uniti d'America 7.458
SG - Singapore 1.848
CN - Cina 1.355
IT - Italia 892
BR - Brasile 763
HK - Hong Kong 562
DE - Germania 524
UA - Ucraina 369
VN - Vietnam 331
FI - Finlandia 306
GB - Regno Unito 298
FR - Francia 240
RU - Federazione Russa 196
TR - Turchia 161
IE - Irlanda 139
IN - India 120
CA - Canada 87
BD - Bangladesh 82
MX - Messico 68
NL - Olanda 58
AR - Argentina 57
ZA - Sudafrica 50
PL - Polonia 46
CZ - Repubblica Ceca 43
BE - Belgio 39
JP - Giappone 39
IQ - Iraq 37
SE - Svezia 31
ES - Italia 29
PK - Pakistan 29
AT - Austria 27
SA - Arabia Saudita 25
ID - Indonesia 21
EC - Ecuador 20
UZ - Uzbekistan 20
VE - Venezuela 19
MA - Marocco 16
PY - Paraguay 15
AU - Australia 14
CO - Colombia 14
IL - Israele 14
TW - Taiwan 12
LT - Lituania 11
CL - Cile 10
JO - Giordania 10
NP - Nepal 10
AZ - Azerbaigian 9
UY - Uruguay 9
AE - Emirati Arabi Uniti 8
EG - Egitto 8
KE - Kenya 8
TN - Tunisia 8
DO - Repubblica Dominicana 7
JM - Giamaica 7
PH - Filippine 7
DK - Danimarca 6
IR - Iran 6
LB - Libano 6
RO - Romania 6
BY - Bielorussia 5
DZ - Algeria 5
KG - Kirghizistan 5
KZ - Kazakistan 5
NG - Nigeria 5
PE - Perù 5
BG - Bulgaria 4
BH - Bahrain 4
BO - Bolivia 4
CR - Costa Rica 4
EE - Estonia 4
ET - Etiopia 4
EU - Europa 4
KR - Corea 4
MD - Moldavia 4
MY - Malesia 4
SN - Senegal 4
AL - Albania 3
CG - Congo 3
CH - Svizzera 3
CI - Costa d'Avorio 3
GE - Georgia 3
GT - Guatemala 3
HN - Honduras 3
OM - Oman 3
PA - Panama 3
XK - ???statistics.table.value.countryCode.XK??? 3
GA - Gabon 2
GD - Grenada 2
GR - Grecia 2
KW - Kuwait 2
LV - Lettonia 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
PT - Portogallo 2
RS - Serbia 2
SI - Slovenia 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
Totale 16.742
Città #
Singapore 990
Ashburn 720
Fairfield 699
Hong Kong 558
San Jose 454
Woodbridge 384
New York 342
Beijing 320
Chandler 318
The Dalles 305
Jacksonville 295
Seattle 254
Wilmington 253
Houston 252
Cambridge 249
Helsinki 231
Ann Arbor 227
Princeton 200
Los Angeles 188
Munich 155
Milan 144
Dublin 138
Lauterbourg 136
Istanbul 128
Ho Chi Minh City 122
Dallas 108
Brescia 102
São Paulo 96
Nanjing 82
Dearborn 75
Redondo Beach 69
Des Moines 68
Shanghai 68
Hanoi 66
San Francisco 64
Moscow 60
Turku 60
Council Bluffs 57
Buffalo 55
Chicago 55
London 49
Santa Clara 47
Rome 46
Jinan 40
Boardman 39
Brussels 39
Warsaw 38
San Diego 37
Nanchang 36
Nuremberg 36
Denver 34
Hebei 33
Johannesburg 32
Orem 32
Changsha 31
Montreal 31
Phoenix 31
Olomouc 30
Tokyo 30
Shenyang 29
Chennai 28
Mexico City 28
Atlanta 27
Frankfurt am Main 27
Brooklyn 25
Charlotte 23
Manchester 23
Lancaster 21
Toronto 21
Belo Horizonte 20
Guangzhou 20
Mumbai 20
Rio de Janeiro 20
Amsterdam 19
Boston 18
Dhaka 18
Stockholm 17
Tashkent 17
Hangzhou 16
Poplar 16
Tianjin 16
Naples 15
Norwalk 15
San Mateo 15
Vienna 15
Bologna 14
Kunming 14
Ningbo 14
Augusta 13
Da Nang 13
Jiaxing 13
Romola 13
Baghdad 12
Brno 12
Haiphong 12
Riyadh 12
Taizhou 12
Washington 12
Brasília 11
Düsseldorf 11
Totale 10.555
Nome #
Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy 306
COVID-19 impact on consecutive neurological patients admitted to the emergency department 255
Discrimination of atypical parkinsonisms with transcranial magnetic stimulation 238
Mild Cognitive Impairment and Progression to Dementia in Progressive Supranuclear Palsy 226
Diagnosis of Mild Cognitive Impairment Due to Alzheimer's Disease with Transcranial Magnetic Stimulation 218
Mendelian forms of disease and age at onset affect survival in frontotemporal dementia 207
Cortico-spinal tDCS in ALS: A randomized, double-blind, sham-controlled trial 206
Stimulation over the cerebellum with a regular figure-of-eight coil induces reduced motor cortex inhibition in patients with progressive supranuclear palsy 185
Transcranial magnetic stimulation distinguishes Alzheimer disease from frontotemporal dementia 182
Autoimmunity and frontotemporal dementia 181
The impact of transcranial magnetic stimulation on diagnostic confidence in patients with Alzheimer disease 180
Validation and convergent validity of the Boston cognitive assessment (BOCA) in an Italian population: a comparative study with the Montreal cognitive assessment (MoCA) in Alzheimer's disease spectrum 178
Anti-GluA3 antibodies in frontotemporal dementia: effects on glutamatergic neurotransmission and synaptic failure 173
Diagnosing Progressive Supranuclear Palsy: Role of Biological and Neuroimaging Markers 169
Metodo di generazione di un indice diagnostico per malattia di alzheimer, apparato elettronico di implementazione del metodo e sistema 169
Clinical and biomarker changes in presymptomatic genetic frontotemporal dementia 169
Enhancing theory of mind in behavioural variant frontotemporal dementia with transcranial direct current stimulation 164
Sensitivity and specificity of transcranial magnetic stimulation for differential diagnosis of Alzheimer’s disease and frontotemporal dementia 163
Cerebellar transcranial direct current stimulation in patients with ataxia: A double-blind, randomized, sham-controlled study. 158
Biological, Neuroimaging, and Neurophysiological Markers in Frontotemporal Dementia: Three Faces of the Same Coin. 151
Natural history and predictors of survival in progressive supranuclear palsy. 151
Author response: Cerebello-spinal tDCS in ataxia: A randomized, double-blind, sham-controlled, crossover trial 150
Neuroanatomical Correlates of Transcranial Magnetic Stimulation in Presymptomatic Granulin Mutation Carriers. 149
Multimodal Brain Analysis of Functional Neurological Disorders: A Functional Stroke Mimic Case Series. 149
Clinical presentation and outcomes of SARS-CoV-2 related encephalitis: the ENCOVID multicentre study 148
Serum neurofilament light in professional soccer players: goal on safety 144
Phenotypic Heterogeneity of Monogenic Frontotemporal Dementia. 143
New insights into the genetic etiology of Alzheimer’s disease and related dementias 142
Response to comments on natural history and predictors of survival in progressive supranuclear palsy 142
The impact of TMS on the differential diagnosis and progression of dementia 142
Method of generation of a diagnostic index for Alzheimer disease, electronic apparatus for implementation of the method and system 140
Phenotypic heterogeneity of Niemann-Pick disease type C in monozygotic twins. 139
Cerebrospinal fluid tau levels predict prognosis in non-inherited frontotemporal dementia. 138
Progression of behavioural disturbances in frontotemporal dementia: a longitudinal observational study 137
Preliminary Results on Long-Term Potentiation-Like Cortical Plasticity and Cholinergic Dysfunction After Miglustat Treatment in Niemann-Pick Disease Type C. 135
Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study 135
Modulating risky decision-making in Parkinson's disease by transcranial direct current stimulation. 135
Clinical, genetic, and neuroimaging features of Early Onset Alzheimer Disease: the challenges of diagnosis and treatment. 134
Italian Frontotemporal Dementia Network (FTD Group-SINDEM): sharing clinical and diagnostic procedures in Frontotemporal Dementia in Italy. 131
Embedded platform-based system for early detection of Alzheimer disease through transcranial magnetic stimulation 130
Facial feedback and autonomic responsiveness reflect impaired emotional processing in Parkinson's Disease. 128
Treatment with docosahexaenoic acid in Spinocerebellar Ataxia 38 128
TMS for staging and predicting functional decline in frontotemporal dementia 128
Classification accuracy of TMS for the diagnosis of mild cognitive impairment 127
MRI data-driven algorithm for the diagnosis of behavioural variant frontotemporal dementia 127
Clinical and neurophysiological characteristics of heterozygous NPC1 carriers 126
Long term clinical and neurophysiological effects of cerebellar transcranial direct current stimulation in patients with neurodegenerative ataxia. 125
Cerebello-spinal tDCS in ataxia: A randomized, double-blind, sham-controlled, crossover trial 125
Recent neuroimaging, neurophysiological, and neuropathological advances for the understanding of NPC 125
Toward a Glutamate Hypothesis of Frontotemporal Dementia 125
Cerebello-spinal stimulation in neurodegenerative ataxia: A randomized, double-blind, sham-controlled, crossover trial 123
Progression of Behavioral Disturbances and Neuropsychiatric Symptoms in Patients With Genetic Frontotemporal Dementia 123
A data-driven disease progression model of fluid biomarkers in genetic frontotemporal dementia 122
Modulation of long-term potentiation-like cortical plasticity in the healthy brain with low frequency-pulsed electromagnetic fields 122
SARS-CoV-2 encephalitis is a cytokine release syndrome: evidences from cerebrospinal fluid analyses 122
Cortical Inhibitory Imbalance in Functional Paralysis 121
An Automated Toolbox to Predict Single Subject Atrophy in Presymptomatic Granulin Mutation Carriers 121
Impaired long-term potentiation-like cortical plasticity in presymptomatic genetic frontotemporal dementia. 120
Hierarchical spectral clustering reveals brain size and shape changes in asymptomatic carriers of C9orf72 119
Mild cognitive impairment in Parkinson's disease is improved by transcranial direct current stimulation combined with physical therapy. 119
Classification Accuracy of Transcranial Magnetic Stimulation for the Diagnosis of Neurodegenerative Dementias 119
Csf p-tau181/tau ratio as biomarker for TDP pathology in frontotemporal dementia. 118
Variability and predictors of response to continuous theta burst stimulation: A TMS-EEG study 118
Data-driven staging of genetic frontotemporal dementia using multi-modal MRI 117
CSF p-Tau181/Tau ratio to distinguish FTLD-TDP from FTLD-Tau 116
Transcranial magnetic stimulation and amyloid markers in mild cognitive impairment: Impact on diagnostic confidence and diagnostic accuracy 116
A panel of CSF proteins separates genetic frontotemporal dementia from presymptomatic mutation carriers: a GENFI study 116
Altered inhibitory interaction among inferior frontal and motor cortex in l-dopa-induced dyskinesias 115
Association of APOE genotype with blood-brain barrier permeability in neurodegenerative disorders 114
Alterations of frontal-temporal gray matter volume associate with clinical measures of older adults with COVID-19 113
Cognitive composites for genetic frontotemporal dementia: GENFI-Cog 113
Expanding the role of education in frontotemporal dementia: a functional dynamic connectivity (the chronnectome) study 111
Stratifying the Presymptomatic Phase of Genetic Frontotemporal Dementia by Serum NfL and pNfH: A Longitudinal Multicentre Study 111
Diagnostic Accuracy of the Five-Word Test for Mild Cognitive Impairment Due to Alzheimer’s Disease 109
Transcranial Magnetic Stimulation in Alzheimer's Disease and Cortical Dementias 108
Imaging features and ultraearly hematoma growth in intracerebral hemorrhage associated with COVID-19 106
Plasma p-tau181 and amyloid markers in Alzheimer's disease: A comparison between Lumipulse and SIMOA 104
CSF p-Tau181/Tau ratio as biomarker for TDP pathology in Frontotemporal Dementia 103
Neurophysiological Correlates of Positive and Negative Symptoms in Frontotemporal Dementia 103
Exposure to gamma tACS in Alzheimer's disease: A randomized, double-blind, sham-controlled, crossover, pilot study 103
Detection of TDP-43 seeding activity in the olfactory mucosa from patients with frontotemporal dementia 102
Impairment of episodic memory in genetic frontotemporal dementia: A genfi study 102
Differences and similarities between familial and sporadic frontotemporal dementia: An Italian single-center cohort study 101
Clinical outcome of neurological patients with COVID-19: the impact of healthcare organization improvement between waves 101
Author Correction: Common variants in Alzheimer's disease and risk stratification by polygenic risk scores 100
Effects of COVID-19 outbreak on stroke admissions in Brescia, Lombardy, Italy 99
Anti-GluA3 autoantibodies define a new sub-population of frontotemporal lobar degeneration patients with distinct neuropathological features 98
Clinical and radiological features of posterior cortical atrophy (PCA) in a GRN mutation carrier: a case report 98
Dissemination in time and space in presymptomatic granulin mutation carriers: a GENFI spatial chronnectome study 98
Differential impairment of cerebrospinal fluid synaptic biomarkers in the genetic forms of frontotemporal dementia 97
Differences Between Plasma and Cerebrospinal Fluid p-tau181 and p-tau231 in Early Alzheimer's Disease 96
Sex Differences in the Severity and Progression of Neuropsychiatric Symptoms Across Different Dementia Types 94
Transcranial stimulation in frontotemporal dementia: A randomized, double-blind, sham-controlled trial 93
Diagnostic and prognostic value of serum NfL and p-Tau181 in frontotemporal lobar degeneration 92
Association of Choroid Plexus Volume With Serum Biomarkers, Clinical Features, and Disease Severity in Patients With Frontotemporal Lobar Degeneration Spectrum 91
Prevalence of cerebrospinal fluid Alzheimer disease-like pattern in atypical dementias 90
Recent advances in understanding frontotemporal degeneration 90
Conceptual framework for the definition of preclinical and prodromal frontotemporal dementia 90
Comparing Cerebellar tDCS and Cerebellar tACS in Neurodegenerative Ataxias Using Wearable Sensors: A Randomized, Double-Blind, Sham-Controlled, Triple-Crossover Trial 89
The CBI-R detects early behavioural impairment in genetic frontotemporal dementia 89
Totale 13.311
Categoria #
all - tutte 88.151
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 88.151


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021239 0 0 0 0 0 0 0 0 0 0 176 63
2021/2022861 61 71 27 34 10 52 86 82 55 97 100 186
2022/20231.072 121 65 48 71 76 244 24 89 148 55 66 65
2023/20241.223 78 32 148 72 37 239 32 55 252 35 37 206
2024/20253.215 46 19 26 524 285 256 235 125 425 307 563 404
2025/20266.472 624 800 492 930 629 508 1.008 310 395 571 205 0
Totale 17.019